Expert opinion on drug delivery最新文献_第2页

Recent developments in nanofiber-based fast-disintegrating drug delivery systems. 基于纳米纤维的快速崩解给药系统的最新进展。

Expert opinion on drug delivery Pub Date : 2025-07-01 Epub Date: 2025-04-29 DOI: 10.1080/17425247.2025.2497831

Fuat Topuz, Tamer Uyar

{"title":"Recent developments in nanofiber-based fast-disintegrating drug delivery systems.","authors":"Fuat Topuz, Tamer Uyar","doi":"10.1080/17425247.2025.2497831","DOIUrl":"10.1080/17425247.2025.2497831","url":null,"abstract":"Introduction: Fast-disintegrating electrospun fibers are emerging as innovative systems for oral drug delivery. These fibers possess a high surface area, porosity, and customizable hydrophilicity, which facilitates quick drug release by disintegrating rapidly in biological fluids or upon contact with water.Areas covered: Hydrophilic polymers and cyclodextrins (CDs), either separately or in combination, are frequently utilized to accelerate the disintegration of electrospun fibers, enhance the solubility of hydrophobic drugs, and improve drug bioavailability, leading to better therapeutic outcomes. Toward this goal, a systematic literature search was conducted to identify experimental studies (2019-2025) in Web of Science, Google Scholar, and Scopus using the keywords ('fast-disintegrating' OR 'fast-dissolving') AND ('electrospinning' OR 'electrospun') AND ('delivery' OR 'release').Expert opinion: This review examines recent advancements over the past five years in the development of fast-disintegrating drug delivery fibers. It analyzes fiber composition, structural modifications, drug encapsulation routes, and their impact on drug release for oral mucosal delivery. Additionally, it addresses the challenges faced and outlines future directions in the field.","PeriodicalId":94004,"journal":{"name":"Expert opinion on drug delivery","volume":" ","pages":"957-969"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144034400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Drug-eluting resorbable coronary scaffolds: a review of recent advances. 药物洗脱可吸收冠状动脉支架：最新进展综述。

Expert opinion on drug delivery Pub Date : 2025-07-01 Epub Date: 2025-04-20 DOI: 10.1080/17425247.2025.2495043

Lowie Vanoverbeke, Johan Bennett

{"title":"Drug-eluting resorbable coronary scaffolds: a review of recent advances.","authors":"Lowie Vanoverbeke, Johan Bennett","doi":"10.1080/17425247.2025.2495043","DOIUrl":"10.1080/17425247.2025.2495043","url":null,"abstract":"Introduction: Device-related persistent adverse events with current DES-use have refocused the attention on a 'leave-nothing-behind' philosophy, in which it is hypothesized that treating coronary stenosis without permanently caging the vessel with a metallic implant would lead to superior clinical outcomes. One of these uncaging technologies is bioresorbable scaffolds (BRS).Areas covered: In this article, we describe the technical specifications and clinical data of currently available BRS devices.Expert opinion: Newer BRS devices have thinner struts and more biocompatible scaffold backbones (either polymer-based or metal-based), resulting in improved radial strength, faster resorption times, and more antithrombogenic properties (e.g. magnesium-based scaffolds). Results of BRS in the treatment of simple coronary artery disease demonstrate favorable clinical efficacy and safety outcome data. It is probable that over the next 5 years more fourth-generation devices with ever-increasing biocompatibility and safety profiles will be investigated and released commercially, resulting in a much more prominent role for BRS, especially in the treatment of simple coronary artery disease in younger patients.","PeriodicalId":94004,"journal":{"name":"Expert opinion on drug delivery","volume":" ","pages":"919-933"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144038910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Can we create customized polypills for personalized drug formulation? 我们可以为个性化的药物配方创造定制的复方药片吗？

Expert opinion on drug delivery Pub Date : 2025-07-01 Epub Date: 2025-04-29 DOI: 10.1080/17425247.2025.2498650

Sheng Qi

引用次数: 0

Role of carbon dots as nanocarriers in drug delivery: current advancements, prospects, and implementations. 碳点作为纳米载体在药物传递中的作用：目前的进展、前景和实现。

Expert opinion on drug delivery Pub Date : 2025-07-01 DOI: 10.1080/17425247.2025.2513439

Zeshan Ali Sandhu, Muhammad Asam Raza, Umme Farwa, Muhammad Saad Fareed, Abdulmajeed Alqurashi, Muhammad Latif

{"title":"Role of carbon dots as nanocarriers in drug delivery: current advancements, prospects, and implementations.","authors":"Zeshan Ali Sandhu, Muhammad Asam Raza, Umme Farwa, Muhammad Saad Fareed, Abdulmajeed Alqurashi, Muhammad Latif","doi":"10.1080/17425247.2025.2513439","DOIUrl":"10.1080/17425247.2025.2513439","url":null,"abstract":"Introduction: Carbon dots (CDs) are recognized as outstanding nanocarriers for drug delivery owing to their superior biocompatibility, straightforward synthetic routes, and tunable surface properties.Area covered: This review presents a comprehensive overview of recent developments in CDs within the context of drug delivery systems (DDSs) and their utilization as carriers for drug loading, stabilization, and delivery. It also describes functionalized CDs for therapeutic applications, including cancer, antimicrobial, and gene therapies. Key strategic issues such as toxicity, biodistribution, and manufacturability are thoroughly elaborated and critically evaluated to identify novel approaches to address crucial challenges.Expert opinion: The promising potential of CDs to transform current drug delivery methods is driving researchers to undertake further biological investigations regarding the application of the CDs in clinical settings, as well as to explore future prospects of CDs within the biomedical field.","PeriodicalId":94004,"journal":{"name":"Expert opinion on drug delivery","volume":" ","pages":"1-23"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144188666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Recent advances in nanocrystals for arthritis drug delivery. 纳米晶体用于关节炎药物递送的最新进展。

Expert opinion on drug delivery Pub Date : 2025-07-01 Epub Date: 2025-05-31 DOI: 10.1080/17425247.2025.2505758

Luca Morici, Olivier Jordan, Eric Allémann, Carlos Rodríguez-Nogales

{"title":"Recent advances in nanocrystals for arthritis drug delivery.","authors":"Luca Morici, Olivier Jordan, Eric Allémann, Carlos Rodríguez-Nogales","doi":"10.1080/17425247.2025.2505758","DOIUrl":"10.1080/17425247.2025.2505758","url":null,"abstract":"Introduction: More than 500 million people worldwide suffer from arthritis, experiencing daily pain and inflammation. Current treatments for osteoarthritis (OA) and rheumatoid arthritis (RA) are palliative, offering only symptom relief. No disease-modifying OA drugs (DMOADs) capable of restoring joint functionality and regenerating the cartilage matrix have yet been approved by the FDA or EMA.Areas covered: This review highlights recent advances in nanocrystals (NCs) for arthritis drug delivery, including conventional nanosuspensions and novel transdermal microneedles. Special attention is given to intra-articular DMOADs formulated as NC-in-microparticles, designed to extend drug release over months. Papers and reviews with the mentioned contents and published over the last 5 years were included in the review process.Expert opinion: New DMOADs and disease-modifying antirheumatic drugs (DMARDs) are often poorly water-soluble, limiting their clinical progress. The versatility of NCs and nanosuspensions offers a potential advantage over other types of nanoparticles, as they can be adapted to various delivery systems, administration routes, and types of arthritis. Due to the avascular nature of cartilage, exploring the intra-articular route for OA management is essential. Implementing cartilage-targeted strategies or using stimuli-responsive hydrogels can further enhance their therapeutic potential.","PeriodicalId":94004,"journal":{"name":"Expert opinion on drug delivery","volume":" ","pages":"1031-1042"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144052411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Future applications of self-immolative polymers in drug delivery. 自焚聚合物在药物传递中的应用前景。

Expert opinion on drug delivery Pub Date : 2025-07-01 Epub Date: 2025-04-15 DOI: 10.1080/17425247.2025.2493228

Elizabeth R Gillies

引用次数: 0

Application of bacteria-mediated gene therapy in tumor treatment. 细菌介导基因治疗在肿瘤治疗中的应用。

Expert opinion on drug delivery Pub Date : 2025-07-01 Epub Date: 2025-05-13 DOI: 10.1080/17425247.2025.2502638

Renjie Feng, Meng Du, Zhiyi Chen

{"title":"Application of bacteria-mediated gene therapy in tumor treatment.","authors":"Renjie Feng, Meng Du, Zhiyi Chen","doi":"10.1080/17425247.2025.2502638","DOIUrl":"10.1080/17425247.2025.2502638","url":null,"abstract":"Introduction: Gene therapy refers to the use of vectors to introduce target genes into target cells to exert a therapeutic effect on tumors. As a new type of tumor therapy, gene therapy has the advantage of precision and specificity. Excellent delivery vehicles have a major impact on the efficiency, precision and safety of gene therapy. Unlike traditional vectors, bacteria based on prokaryotes have the advantages of good targeting, large load, and simplicity. In addition, different types of bacteria also have characteristics that can be used in various scenarios.Areas covered: In this review, we searched the gene therapy-related literature in PubMed, mainly in the last five years, and compared the characteristics of different gene vectors, focusing on the bacterial gene therapy and aiming to explore excellent bacterial gene therapy programs.Expert opinion: Compared with traditional tumor gene therapy vectors, bacteria have many advantages, such as good targeting, large carrying capacity, and simple production. Meanwhile, the combination of artificial intelligence technology, bacterial imaging probe technology and suicide genes will be expected to control the bacterial therapy process, improve the safety of treatment, and promote the translational application of bacterial gene therapy.","PeriodicalId":94004,"journal":{"name":"Expert opinion on drug delivery","volume":" ","pages":"993-1006"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144058984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Explicating the transformative role of artificial intelligence in designing targeted nanomedicine. 阐述人工智能在设计靶向纳米药物中的变革作用。

Expert opinion on drug delivery Pub Date : 2025-07-01 Epub Date: 2025-05-21 DOI: 10.1080/17425247.2025.2502022

Masheera Akhtar, Nida Nehal, Azka Gull, Rabea Parveen, Sana Khan, Saba Khan, Javed Ali

{"title":"Explicating the transformative role of artificial intelligence in designing targeted nanomedicine.","authors":"Masheera Akhtar, Nida Nehal, Azka Gull, Rabea Parveen, Sana Khan, Saba Khan, Javed Ali","doi":"10.1080/17425247.2025.2502022","DOIUrl":"10.1080/17425247.2025.2502022","url":null,"abstract":"Introduction: Artificial intelligence (AI) has emerged as a transformative force in nanomedicine, revolutionizing drug delivery, diagnostics, and personalized treatment. While nanomedicine offers precise targeted drug delivery and reduced toxic effects, its clinical translation is hindered by biological complexity, unpredictable in vivo behavior, and inefficient trial-and-error approaches.Areas covered: This review covers the application of AI and Machine Learning (ML) across the nanomedicine development pipeline, starting from drug and target identification to nanoparticle design, toxicity prediction, and personalized dosing. Different AI/ML models like QSAR, MTK-QSBER, and Alchemite, along with data sources and high-throughput screening methods, have been explored. Real-world applications are critically discussed, including AI-assisted drug repurposing, controlled-release formulations, and cancer-specific delivery systems.Expert opinion: AI has emerged as an essential component in designing next-generation nanomedicine. Efficiently handling multidimensional datasets, optimizing formulations, and personalizing treatment regimens, it has sped up the innovation process. However, challenges like data heterogeneity, model transparency, and regulatory gaps remain. Addressing these hurdles through interdisciplinary efforts and emerging innovations like explainable AI and federated learning will pave the way for the clinical translation of AI-driven nanomedicine.","PeriodicalId":94004,"journal":{"name":"Expert opinion on drug delivery","volume":" ","pages":"971-991"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143995215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Progress and potential of nanobubbles for ultrasound-mediated drug delivery. 纳米气泡在超声介导药物传递中的研究进展及潜力。

Expert opinion on drug delivery Pub Date : 2025-07-01 Epub Date: 2025-05-18 DOI: 10.1080/17425247.2025.2505044

Laura E Chen, Pinunta Nittayacharn, Agata A Exner

{"title":"Progress and potential of nanobubbles for ultrasound-mediated drug delivery.","authors":"Laura E Chen, Pinunta Nittayacharn, Agata A Exner","doi":"10.1080/17425247.2025.2505044","DOIUrl":"10.1080/17425247.2025.2505044","url":null,"abstract":"Introduction: Despite much progress, nanomedicine-based drug therapies in oncology remain limited by systemic toxicity and insufficient particle accumulation in the tumor. To address these barriers, formulations responsive to external physical stimuli have emerged. One most promising system is the ultrasound stimulation of drug-loaded, gas-core particles (bubbles). Ultrasound induces bubble cavitation for cell and tissue permeabilization, triggers on-demand drug release, and provides opportunities for real-time imaging of delivery.Areas covered: Here, we focus on shell-stabilized, gas-core nanoparticles (also termed nanobubbles or ultrafine bubbles) and their role in ultrasound-mediated therapeutic delivery to tumors. This review frames the advantages of nanobubbles within the ongoing deficits in nanomedicine, describes mechanisms of ultrasound-mediated therapy, and details formulation techniques for nanobubble delivery systems. It then highlights the past decade of research in nanobubble-facilitated drug delivery for cancer therapy and anticipates new directions in the field.Expert opinion: Nanobubble ultrasound contrast agents offer a spatiotemporally triggerable therapeutic coupled with a safe, accessible imaging modality. Nanobubbles can be loaded with diverse therapeutic cargoes to treat disease and overcome numerous barriers limiting delivery to solid tumors. Close attention to formulation, characterization methods, acoustic testing parameters, and the biological mechanisms of nanobubble delivery will facilitate preclinical research toward clinical adoption.","PeriodicalId":94004,"journal":{"name":"Expert opinion on drug delivery","volume":" ","pages":"1007-1030"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12213167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144059021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Transfersomes: a next-generation drug delivery system for topical ocular drug delivery. 转移体：用于眼部局部药物传递的下一代药物传递系统。

Expert opinion on drug delivery Pub Date : 2025-07-01 Epub Date: 2025-05-05 DOI: 10.1080/17425247.2025.2497829

Santosh Bhujbal, Ilva D Rupenthal, Vandana B Patravale, Priyanka Agarwal

{"title":"Transfersomes: a next-generation drug delivery system for topical ocular drug delivery.","authors":"Santosh Bhujbal, Ilva D Rupenthal, Vandana B Patravale, Priyanka Agarwal","doi":"10.1080/17425247.2025.2497829","DOIUrl":"10.1080/17425247.2025.2497829","url":null,"abstract":"Introduction: The eye is a complex organ with several anatomical and physiological barriers that make ocular drug delivery an ongoing challenge. Transfersomes (TFS) are deformable vesicles that have been extensively applied to enhance transdermal drug delivery. However, their application in ocular drug delivery remains largely unexplored.Areas covered: This review highlights the challenges typically associated with ocular drug delivery and emphasizes the inherent properties of TFS that enable them to overcome these challenges. The influence of excipients and critical process parameters on TFS characteristics have been discussed in detail with an emphasis on the fabrication and characterization techniques typically employed for TFS development and optimization. Furthermore, recent studies evaluating the application of TFS in ocular drug delivery have been discussed in depth.Expert opinion: The unique stress-responsive and deformable nature of TFS makes them promising carriers for ocular drug delivery. However, further research in this direction is needed to understand their penetration mechanism and elucidate their potential for sustained and targeted drug delivery to ocular tissues. Moreover, further research is needed to optimize the stability and scalability of TFS to encourage their translation to the market.","PeriodicalId":94004,"journal":{"name":"Expert opinion on drug delivery","volume":" ","pages":"935-956"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144015677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0